Helping preemies absorb food

The ELGN-GI insulin formulation developed by Israel’s Elgan can save the lives of preterm babies with immature stomachs that cause feeding intolerance. It will avoid the adverse effects of intravenous nutrition, which often leads to infection and liver problems. A Phase 3 trial is being planned.

https://www.jpost.com/health-and-wellness/pregnancy-and-birth/article-699123

https://www.elganpharma.com/

http://www.ngt3vc.com/elgan-pharma/

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.